Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 2 2Phase 4 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neuroendocrine Tumors 4Neoplasms 2Acromegaly 2Serotonin Syndrome 1Pituitary Neoplasms 1Pancreatitis 1Pancreatic Intraductal Neoplasms 1Gastro-enteropancreatic neuroendocrine tumor 1Fistula 1Duodenal Neoplasms 1Diarrhea 1Colorectal Neoplasms 1Carcinoid Tumor 1Breast Neoplasms 1Brain Neoplasms 1Adenoma 1

Interventions

Octreotide 1Control Groups 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Diarrhea × Octreotide × Clear all
NCT00050635 2009-11-19

STOP Trial - Sandostatin LAR Depot Trial for the Optimum Prevention of Chemotherapy Induced Diarrhea

Novartis

Phase 4 Completed
150 enrolled
Gastrointestinal

Diarrhea, Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡